George M. Lasezkay

Insider Reports History

Entity
Individual
Location
1301 Second Ave., Suite 4200, Seattle, WA
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by George M. Lasezkay:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Clearside Biomedical, Inc. CEO, Director Common Stock 467K $593K $1.27 Jan 19, 2024 Direct
Clearside Biomedical, Inc. CEO, Director Employee Stock Option (right to buy) 440K Jan 18, 2024 Direct

Insider Reports Filed by George M. Lasezkay

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CLSD Clearside Biomedical, Inc. Jan 18, 2024 2 -$22.9K 4 Jan 19, 2024 CEO, Director
CLSD Clearside Biomedical, Inc. Sep 18, 2023 1 $0 4 Sep 20, 2023 CEO, Director
CLSD Clearside Biomedical, Inc. Jan 19, 2023 1 -$29.2K 4 Jan 20, 2023 CEO, Director
CLSD Clearside Biomedical, Inc. Jan 4, 2023 1 $0 4 Jan 6, 2023 CEO, Director
CLSD Clearside Biomedical, Inc. Jan 18, 2022 3 -$22.9K 4 Jan 20, 2022 CEO, Director
CLSD Clearside Biomedical, Inc. Jan 11, 2022 1 -$12.5K 4 Jan 13, 2022 CEO, Director
CLSD Clearside Biomedical, Inc. Sep 21, 2021 1 -$22.8K 4 Sep 23, 2021 CEO, Director
CLSD Clearside Biomedical, Inc. Jun 21, 2021 1 -$16.2K 4 Jun 23, 2021 CEO, Director